Recent Finacing
Recent Raise
Pheast Therapeutics is a Palo Alto–based preclinical immuno-oncology company developing innate immune‑activating checkpoint therapies targeting CD24 and using a proprietary discovery platform to generate tumor‑specific immunotherapies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
